Showing results (1-10 of 223) with videos related to
Sort By:
Pageof 23
Microorganisms|November 27, 2024
Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative ReviewPoonam Mathur, Arshi Khanam, Shyam KottililPathogens (Basel, Switzerland)|August 28, 2025
Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and TherapyArshi Khanam, Abutaleb Ameer, Poonam Mathur, et al.Frontiers in Medicine|November 25, 2021
Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and ManagementArshi Khanam, Shyam KottililInternational Journal of Molecular Sciences|January 8, 2023
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?Arshi Khanam, Shyam KottililFrontiers in Immunology|October 29, 2020
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for TherapeuticsArshi Khanam, Shyam KottililFrontiers in Immunology|May 14, 2023
CD38: an ecto-enzyme with functional diversity in T cellsAlip Ghosh, Arshi Khanam, Krishanu Ray, et al.Cells|June 2, 2021
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Arshi Khanam, Paul G Saleeb, Shyam KottililInternational Journal of Molecular Sciences|June 2, 2021
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionArshi Khanam, Joel V Chua, Shyam KottililHepatology (Baltimore, Md.)|October 24, 2021
Programmed death 1 expressing CD8+ CXCR5+ follicular T cells constitute effector rather than exhaustive phenotype in patients with chronic hepatitis BArshi Khanam, Lydia S Y Tang, Shyam KottililJournal of Translational Medicine|April 20, 2023
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathwaysArshi Khanam, Alip Ghosh, Joel V Chua, et al.Pageof 23